From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Topics>
  3. Osteoporosis/Bone Disease>
  4. Archives

Osteoporosis/Bone Disease: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

Items 101-125 of 233 are shown

Modifiable Factors That Increase Mortality After Hip Fracture

Delayed surgery and general anesthesia were associated with worse outcomes.

If a Bone Breaks, Think Osteoporosis

Both high- and low-trauma fractures could indicate underlying osteoporosis.

Are Simple Tools Effective for Assessing Hip Fracture Risk?

Eleven clinical variables predicted 5-year hip fracture risk almost as well as did bone densitometry.

Etiology of Knee Buckling

Sudden loss of support at the knee commonly has a musculoskeletal etiology.

Benefits and Risks of Long-Term Alendronate

The FLEX study results help us determine for whom long-term alendronate therapy is beneficial.

Depression and Low Bone Mass

Depressed women had lower BMD and higher levels of several proinflammatory markers.

ANCA Levels and Disease Activity in Wegener Granulomatosis

Increased ANCA levels in patients in sustained remission should not prompt presumptive therapy without clinical evidence of disease activity.

Dabigatran: A New Oral Anticoagulant

In a large study, dabigatran was as effective as low-dose enoxaparin for preventing VTE after knee replacement.

Depression: Can You Feel It in Your Bones Even After It’s Gone?

An observational study confirms depression as a risk factor for osteoporosis in women.

Clinical Predictors of Hip Fracture in Postmenopausal Women

A new algorithm accurately predicts 5-year risk; the next step is to test its clinical utility prospectively.

Lumbar Supports Prevent Recurrent Low Back Pain in the Workplace

Elastic back supports reduced recurrence of low back pain among home-care workers.

High-Trauma Fractures and Osteoporosis

Osteoporosis predicts high-trauma as well as low-trauma fractures.

Acute Lower Back Pain: Keep Things Simple

NSAIDs and spinal manipulation did nothing to speed recovery.

Parathyroid Hormone vs. Alendronate for Steroid-Induced Osteoporosis

Parathyroid hormone was associated with significantly greater increases in BMD and fewer vertebral fractures — but not nonvertebral fractures.

Does Keyboard Use Increase the Risk for Carpal Tunnel Syndrome?

This study suggested an inverse relation between use and risk, but questions remain.

Biologic Therapy Apparently More Effective Than Oral Therapy for Glucocorticoid-Associated Osteoporosis

Teriparatide was associated with greater bone density and fewer vertebral fractures in corticosteroid recipients, but the therapy is costly.

The Importance of Knee Buckling

More than 10% of adults reported knee buckling in the past 3 months.

Protection for Those Who Have Experienced Hip Fracture

Annual intravenous bisphosphonate therapy prevented new osteoporotic fractures.

Weight Control and Bone Density During the Menopausal Transition

A healthful diet and exercise program has a downside: loss in BMD.

Preventing Subsequent Fractures After Hip Fracture

Zoledronic acid was effective for secondary prevention.

OC Effect on Bone Density: Still Not Clear

Among female military cadets, oligomenorrhea and current OC use were associated with reduced BMD at certain skeletal sites.

Aromatase-Inhibitor–Induced Joint Complaints: An Underappreciated Problem?

Joint complaints are common among women who receive AIs.

Is "Chronic Lyme Disease" Real?

Patients with chronic symptoms but no objective criteria for infection are receiving long-term antibiotic therapy.

Joint Symptoms in Women Taking Aromatase Inhibitors for Breast Cancer

Patients who received aromatase inhibitors commonly reported joint symptoms.

Raloxifene Approved for Lowering Breast Cancer Risk in Postmenopausal Women

The FDA has approved a second SERM for breast cancer chemoprophylaxis.

Items 101-125 of 233 are shown

Search

Advanced

Sign-In

Forgot your password?

New to Journal Watch?





Copyright © 2009. Massachusetts Medical Society. All rights reserved.